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Background: The 4q- syndrome is a well known genetic condition caused by a partial terminal or interstitial
deletion in the long arm of chromosome 4. The great variability in the extent of these deletions and the possible
contribution of additional genetic rearrangements, such as unbalanced translocations, lead to a wide spectrum of
clinical manifestations. The majority of reports of 4q- cases are associated with large deletions identified by
conventional chromosome analysis; however, the widespread clinical use of novel molecular techniques such as
array comparative genomic hybridization (a-CGH) has increased the detection rate of submicroscopic chromosomal
aberrations associated with 4q- phenotype.
Results: Herein we report two prenatal cases of 4qter deletions which presented the first with no sonographic
findings and the second with brain ventriculomegaly combined with oligohydramnios. Standard karyotyping
demonstrated a deletion at band q35.1 of chromosome 4 in both cases. The application of a-CGH confirmed the
diagnosis and offered a precise characterization of the genetic defect.
Conclusions: We provide a review of the currently available literature on the prenatal diagnostic approach of
4q- syndrome and we compare our results with other published cases. Our data suggest that the identification
and the precise molecular characterization of new cases with 4q- syndrome will contribute in elucidating the
genetic spectrum of this disorder.
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The 4q deletion syndrome is a rare chromosomal disorder
caused by a partial deletion of the long arm of chromo-
some 4, with an estimated incidence of 1 in 50,000-
100,000 [1,2]. Since the first description of a deletion at
the terminal region of the long arm of chromosome 4 by
Ockey et al. in 1967, more than 150 literature cases have
been reviewed and delineated as 4q- syndrome [3], most
of them diagnosed postnatally. The majority of deletions
are de novo but approximately 14% of cases result from
unbalanced segregation of parental reciprocal traslocations
[2]. Male to female ratio is approximately equal 48:53. The* Correspondence: emanolakosgr@yahoo.gr
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reproduction in any medium, provided the or4q- cases can be further classified depending on the exact
chromosome breakpoints.
Common phenotypic characteristics of 4q- syndrome
are mild dysmorphic features, craniofacial, digital, skel-
etal, gastro-intestinal, cardiac and urogenital anomalies,
while most probands are presented with variable devel-
opmental delay and growth deficiency [1,4-7].
In literature, the majority of postnatally diagnosed
cases are associated with large 4q deletions identified by
conventional chromosome analysis. However, nowadays
the widespread clinical use of novel high-resolution mo-
lecular techniques such as array comparative genomic
hybridization (a-CGH), has increased the detection rate
of submicroscopic chromosomal aberrations that could
also lead to a 4q- phenotype. In this report, we applied
genome-wide array-CGH to investigate further, two cases
detected prenatally with distal deletions of chromosometral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A 36-year-old primigravida was referred to our clinic at
19 weeks of gestation due to IVF and parental anxiety.
The family history was unremarkable and the first-
trimester screening test for chromosomal aneuploidy
was normal. No fetal malformation was present in ultra-
sound scan. Amniocentesis was performed and karyo-
type analysis led to the diagnosis of a 4qter deletion
which was further confirmed by a-CGH. After genetic
counselling, termination of pregnancy was performed at
parent’s request at 22 weeks of gestation. A male neo-
nate was delivered vaginally after medical induction with
prostaglandins. Necropsy showed a male fetus with
macrocephaly, depressed nasal bridge, micrognathia, car-
pal flexion, and clinodactyly.
Case 2
A 27-year-old primigravida was referred to our clinic at
22 weeks gestation for genetic counselling due to pres-
ence of brain ventriculomegaly and oligohydramnios
in the detailed second trimester anomaly ultrasound
scan. The first trimester screening test for fetal aneu-
ploides was normal and the couple was healthy, no
consanguineous, with unremarkable medical history. In-
vasive testing was offered and amniocentesis was per-
formed. Karyotype analysis led to the diagnosis of a
4qter deletion and array-CGH analysis confirmed with
high precision a 8.0 Mb terminal 4q deletion, in the area
4q35.1-qter. After extensive counselling, the family de-
cided to terminate the pregnancy and agreed to an aut-
opsy of the fetus. A male stillborn neonate was delivered
at 24 weeks after medical induction with prostaglandins.
Fetal autopsy revealed a fetus which was appropriate for
age, weighing 692 g and measuring 22.5 cm in CRL and
50 mm in foot length. Dysmorphic craniofacial features
included macrocephaly, hypertelorism, beaked nose, de-
pressed nasal bridge, increased hair growth with low
frontal and cervical hairline and hair extending onto the
lateral cheeks. Increased hair growth was also noted on
the back and arms. The neck was broad and short. Limb
deformities included camptodactyly, overlapping fingers,
and “rocker bottom” feet with prominent heels. External
genitalia were of normal male. On dissection, the anter-
ior fontanelle was distended; measuring 4.0 × 2.8 cm.
Neuropathological examination was not feasible due to
brain autolysis. The diaphragm was membranous. Organ
weights were appropriate for age. Microscopy showed
increased erythropoiesis in the liver. No further gross
or histologic abnormalities were noted. According toexternal maceration and autolytic lesions of fetal tissues,
intrauterine fetal death was approximately dated 24 h
before delivery.
The placenta, 113 g of weight, was very small for
gestational age, with a partially extrachorial configur-
ation and histologic findings of maternal hypoperfu-
sion and decidual vasculopathy. The umbilical cord
inserted peripherally.
Cytogenetic and molecular cytogenetic analysis
Cytogenetic analysis was performed on cultured amnio-
cytes and revealed a male karyotype with a terminal de-
letion of the long arm of one chromosome 4 in both
cases. The karyotype was described as 46,XY,del(4)
(q35.1) according to ISCN 2013. Parental karyotyping
was found to be normal (data not shown) in both cases.
The two aberrations were further investigated using
array-CGH technique. In case 1, a-CGH analysis de-
tected a 8.18 Mb deletion which proximal and distal
breakpoints fell between 182,717,805 and 190,896,815
bp (last oligonucleotide probe available on platform), re-
spectively, extending from 4q35.1 to the subtelomeric
region of 4q35.2 (Figure 1). In case 2 the chromosome 4
abnormality was further delineated as a 8 Mb deletion
which proximal and distal breakpoints fell between
182,920,816 and 190,896,815 bp (last oligonucleotide
probe available on platform), respectively (Figure 1). The
positions of oligomers refer to the Human Genome
February 2009 (versions GRCh37, hg19) assembly.
Discussion
Routine prenatal chromosome analysis identifies rarely
chromosomal anomalies under 5 Mb, whilst array-CGH
can detect small chromosomal imbalances anywhere in
the genome [8]. Moreover, array-CGH has the potential
to define exactly the size of the deletion and its gene
content, at a much higher resolution than karyotyping,
thus making easier a genotype-phenotype correlation in
many cases. Recent studies have demonstrated that care-
ful implementation of high resolution array testing
would benefit at least 2-10% of obstetric patients with
abnormal ultrasound findings and a normal karyotype,
by revealing genetic rearrangements with clinical signifi-
cance [9,10]. Furthermore, genome-wide array is now
considered essential for the prenatally characterization
of findings with elusive clinical significance, such as ap-
parently balanced de novo chromosome rearrangements,
supernumerary marker chromosomes of unknown origin
and structural variations not classified as already known
benign polymorphisms [11]. However, conventional
karyotyping can detect balanced rearrangements such as
reciprocal and Robertsonian translocations, inversions
and balanced insertions. These alterations would have
gone undetected by microarray analysis, therefore not
Figure 1 UCSC genome browser (GRCh37/hg19) illustration of the terminal region of the long arm of chromosome 4 from base pairs
182,500,000 in 4q34.3 to 191,000,000 in 5p13.3. The region is indicated by the rectangle on the idiogram of chromosome 4. The
corresponding deleted segments in our two cases are highlighted in red, while the gene content is also displayed. The overall size of the
deletion was about 8 Mb in both cases.
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balanced offspring in the future [11]. The majority of
prenatally diagnosed cases of 4q- syndrome reported in
the literature are delineated by conventional cytogenetic
analysis, but during the last decade the availability of
new technologies especially a-CGH, have enabled a more
precise description of the molecular mechanisms that
can account for the 4q- phenotype [12].
We report two prenatal cases of 4q- syndrome. The
first was presented with normal ultrasound findings and
prenatal testing was offered due to increased maternal
age and parental anxiety. The second was referred to
our laboratory due to presence of brain ventriculomegaly
and oligohydramnios. After invasive testing, conven-
tional cytogenetic investigation led to diagnosis of a ter-
minal 4q deletion at region q35.1 in both cases. In
addition, molecular analysis of cultured amniocytes with
a-CGH further defined the precise breakpoints of the two
aberrations (Figure 1), revealing two terminal deletions ap-
proximately 8 Mb in size respectively. Interestingly, only a
few prenatally diagnosed cases of 4q- syndrome have been
reported in the bibliography. In Table 1, we summarize
the clinical features of six prenatal cases (included ours)
with pure, terminal deletions of the segment 4q33-qter or
a part of it.
4q deletion syndrome is a distinct congenital malfor-
mation syndrome associated with various clinical find-
ings affecting multiple systems and organs, including
facial and digital dysmorphology, Pierre Robin sequence,
developmental delay, autistic spectrum disorder, and ab-
normalities of the cardiovascular, musculoskeletal and
gastrointestinal systems [12]. However, several reports of
concomitant 4q- and other structural chromosomal ab-
errations, as a result of de novo or inherited unbalanced
translocations involving a deletion on chromosome 4
and a partial trisomy for another chromosome arm, dis-
play complex phenotypes and confuse some of the cor-
relations [2].About 40 genes with either known or unknown func-
tions are included in the deleted 4q35.1-qter region
(182.7 to 190.9 Mb). More specifically these genes en-
code enzymes (ENPP6, F11, CYP4V2, DCTD, KLKB1,
ACSL1), signal receptors and transducers (MTNR1A,
SORBS2, FAT1), structural proteins (MLF1IP, PDLIM3,
CLDN22), one protein member of caspase family (CASP3),
one transporter in mitochondrial membrane (SLC25A4),
two transcription factors (HELT, IRF-2) and two proteins
implicated in innate immunity (TLR-3, IRF-2). Four of
these genes are reported as disease genes in OMIM data-
base. Specifically SLC25A4 is connected with progressive
external ophthalmoplegia and familial hypertrophic car-
diomyopathy, TLR-3 with susceptibility or resistance to
some kinds of infections, F11 with deficiency in coagula-
tion factor XI and CYP4V2 with Bietti crystalline corneor-
etinal dystrophy. However, none of these, alone, can
account for the 4q- syndrome phenotype. After taking into
consideration all the published cases and two of their own,
Rossi et al., suggested a 3 Mb interval of terminal 4qter,
which possibly contains haploinsufficient genes and is
responsible for 4q- syndrome [14]. This region extends
from 186 to 189 Mb and the candidate genes are HELT,
LRP2BP, SORBS2 and FAT1. It is worth taking into con-
sideration that the same region is included in both de-
letions here described. Recently, Strehle et al. published
a genotype-phenotype analysis of 20 individuals with
4q- syndrome and variable extent of deletions, which
were assessed by a-CGH technique. The author suggested
that the critical region for the syndrome resides in 4q35.1,
implicating gene SORBS2 for orofacial clefts and con-
genital heart defects [12]. SORBS2 encodes a protein con-
taining N-terminal sorbin and a C-terminal SH3 domain,
acting as signal transducer in epithelial and cardiac
muscle cells, possibly by linking Abl family kinases and
the actin cytoskeleton.
Interestingly, although SORBS2 gene is deleted in our
two described cases, however no cleft palate was present.
Table 1 Clinical findings in prenatally diagnosed cases with overlapping chromosome 4q terminal deletions
Studies Russel et al. 2008 [13] Rossi et al. 2009 [14] Rossi et al. 2009 [14] Strehle et al. 2012 [3] Curent Current
Case 1 Case 2 Case 1 Case 1 Case 2
Deletion 4q33-qter 4q34.1-qter 4q34.1-qter 4q33-qter 4q35.1-qter 4q35.1-qter
Size - 12.6 16.5 - 8.2 8.0
Start Seq. 178.5 174.6 - 182.7 182.9
End Seq. 191.1 191.1 - 190.9 190.9
Gestation age 32 w 13 w - 13 w 19 w 22 w
Sex (M/F) F F F F F M
Maternal age 31 y 33 y n.d. 43 y 36 y 28 y
Pregnancy length 34 wks term term TOP at 18+5 w TOP at 22 w TOP at 24 w
Birth weight (g) 2,660 3,490 5th percentile - - 692
Birth length (cm) 45 53.5 5th percentile - - 50 mm
Birth OFC (cm) n.d. 36 - - - -
Growth retardation Yes - - No No No
Mental retardation - LD Yes - - -
Cranial/Facial
abnormalities
Yes Yes Yes Yes Yes Yes
Microcephaly No - - - No No
Macrocephaly No - - - Yes Yes
Forehead High - - - - -
Eyes - Iris coloboma Myopia - - Hypertelorism
Nose Small with narrow
bridge and anteverted
nares
- Short nose - Depressed
nasal bridge
Beaked
Micrognathia Yes Yes - - No No
Heart VSD VSD, PDA - Normal No No
Limb abnormalities Yes - - - yes Yes
Hands 4th and 5th fingers
bilaterally
- Clinodactyly of the left
and right fifth toes
- Clinodactyly Campodactyly
Feet Short - - - - -
-, absence; n.d, not determined; TOP, termination of pregnancy; VSD, ventricular septal defect; PDA, patent ductus arteriosus; LD, learning disabilities in carrier
mother.
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for clefts or influencing palate development should res-
ide in 4q33-4q35.1, but it could not be exactly located
yet [12]. The author describes a patient (case 20) with a
minimal deletion in 4q35.1 (186.7-187.2 Mb) who is pre-
sented with cleft palate. However, he also reports other
cases with larger deletions in the same area, who do not
display the same feature (cases 14, 16, 18, 19) [12].
Moreover, Rossi et al. after considering their two cases
and the current literature, suggested that the region re-
sponsible for cleft palate should reside between 174 to
178 Mb in 4q34.1-4q34.2 [14]. Taking in account all
these contradictory observations, we can hypothesize
that other genes or genetic factors could modify the
phenotype in each particular case, thus rendering the
efforts of determining the responsible gene(s) a challen-
ging task.Conclusions
In conclusion 4q- syndrome is associated with facial dys-
morphism and/or other major malformations such as
skeletal abnormalities, midline fusion defects and renal
hypoplasia. These findings may be indicative of a 4q-
case and should trigger cytogenetic investigation that
will eventually lead to an accurate diagnosis. In our
cases, we applied array-CGH analysis in two 4q- fetuses
with cytogenetically visible deletions so as to confirm
that they were pure distal deletions, to define their ex-
tent at molecular level and to establish a firm diagnosis.
Standard chromosome analysis that reveals a normal
karyotype, may lead to false interpretations and further
investigation with high-resolution techniques such as
array-CGH is nowadays strongly recommended, par-
ticularly in case of discordance between prenatal ultra-
sound findings and normal karyotype. In the future, the
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http://www.molecularcytogenetics.org/content/6/1/47implementation of this technique in the routine prac-
tice of prenatal diagnosis will improve the diagnostic
yield in pregnancies with abnormal ultrasound findings
and particularly to 4q-, it will enable a more precise es-
timation of the true incidence of the syndrome and
shall advance our knowledge regarding the genotype-
phenotype correlations.
Methods
Amniotic fluid was collected from case 1 and case 2 at 19
and 22 weeks of gestation, respectively. Cytogenetic ana-
lysis was performed on cultured amniocytes by G-banding
according to standard procedures. At least 20 metaphases
from two different cultures were analyzed per case.
Chromosome analysis of parental blood samples was per-
formed using GTG-banding techniques on stimulated
blood lymphocytes at 550–600 band resolution.
Array-CGH was performed on DNA from cultured
amniocytes to characterize the extent of the deletions
using an 80 kb resolution array (kit 60 K). Molecular
karyotyping was carried out through oligonucleotide
array-CGH platforms (Agilent Technologies, Santa
Clara, CA) as described elsewhere [15]. The positions of
oligomers refer to the Human Genome February 2009
(versions GRCh37, hg19) assembly.
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